Defunct Company
Total Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
2,692
NCT00484900
Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria
Phase: Phase 3
Role: Lead Sponsor
Start: May 31, 2006
Completion: May 31, 2007
NCT00529867
Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria
Phase: Phase 4
Start: May 31, 2007
Completion: Dec 31, 2007
NCT00510159
Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis
Phase: Phase 2/3
Start: Aug 31, 2007
NCT00764036
Study of Artesunate in Metastatic Breast Cancer
Phase: Phase 1
Role: Collaborator
Start: Oct 31, 2008
Completion: Nov 30, 2013
NCT01054651
A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni
Start: Oct 31, 2009
Completion: Dec 31, 2009